Xenetic

Biopharmaceutical company advancing immune-oncology technologies for high-value cancer indications

placeCambridge, Massachusetts, United States calendar_todayFounded 2011 groups4 employees language xeneticbio.com

Registered entities

Social engagement

Social engagement: 1K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

5 investors on record.

Investor typeCountShare
Other / undisclosed5100%

Recent activity

13 May 2026
Milestone
regulatory
Coming soon